Furthermore, this model will be used to screen potential drugs targeting the angiogenic markers, such as VEGF, ANG2, and MMP9, which will help reduce adipocyte hypertrophy and the formation of dysfunctional microvasculature, thereby providing new treatment opportunities for lipedema. Here, ANGPT2 is linked to Lipedema.